Home › Books › Panel ties on new indication for wakefulness drug: 4-4 spli…
Panel ties on new indication for wakefulness drug: 4-4 split on Provigil.(News): An article from: Clinical Psychiatry News Buy on Amazon

https://www.ebooknetworking.net/books_detail-B0008GATB6.html

Panel ties on new indication for wakefulness drug: 4-4 split on Provigil.(News): An article from: Clinical Psychiatry News

AuthorDeeanna Franklin
PublisherInternational Medical News Group
Shop on Amazon — choose your country
🇺🇸 USA 🇨🇦 Canada 🇬🇧 UK 🇩🇪 Germany 🇫🇷 France 🇮🇳 India
5.95 USD
Buy New on Amazon 🇺🇸

Book Details

Author(s)Deeanna Franklin
PublisherInternational Medical News Group
ISBN / ASINB0008GATB6
ISBN-13978B0008GATB8
MarketplaceUnited States  🇺🇸

More Books by Deeanna Franklin

FDA panel recommends OTC status for Prilosec. (Vote Was 16-2 in Favor).: An article from: OB GYN News
FDA panel recommends OTC status for Prilosec. (Vote Wa…
View
FDA panel recommends adding folic acid to OCs: product concept.: An article from: Family Practice News
FDA panel recommends adding folic acid to OCs: product…
View
The art of Michael Madore.(Visionary Art): An article from: Clinical Psychiatry News
The art of Michael Madore.(Visionary Art): An article …
View
FDA panel recommends pairing folic acid/OCs.(News)(Food and Drug Administration)(oral contraceptive): An article from: Clinical Psychiatry News
FDA panel recommends pairing folic acid/OCs.(News)(Foo…
View
Comparison of clinical trials: olanzapine may pose mortality risk in dementia.(Focus on Geriatric Mental Health): An article from: Internal Medicine News
Comparison of clinical trials: olanzapine may pose mor…
View
The art of Peta Wright.(Visionary Art): An article from: Clinical Psychiatry News
The art of Peta Wright.(Visionary Art): An article fro…
View
Dental exam for pediatricians: Will you pass? (The Questions Parents will Ask).: An article from: Pediatric News
Dental exam for pediatricians: Will you pass? (The Que…
View
Advisory panel: streamline how FDA guages new acne drugs' effectiveness. (Total Lesion Count 'Irrelevant').(Food and Drug Administration): An article from: Skin & Allergy News
Advisory panel: streamline how FDA guages new acne dru…
View
FDA Panel Backs OTC Status for Allergy Drugs.(Brief Article): An article from: Family Practice News
FDA Panel Backs OTC Status for Allergy Drugs.(Brief Ar…
View
FDA Panel Backs OTC Status of Allergy Drugs.: An article from: Pediatric News
FDA Panel Backs OTC Status of Allergy Drugs.: An artic…
View
Donate to EbookNetworking
Prev
Next